Acute Graft Versus Host Disease - 162 Studies Found
| Enrolling by invitation |
: Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease : Acute GVH Disease : 2012-11-11 : Biological: Human Umbilical Cord Derived MSC 1×10^6 UC-MSCs per kg intravenous injection the number |
| Completed |
: Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD : Acute GVH Disease : 2015-03-19 :
|
| Completed |
: Fecal Microbiota Transplantation in Gut aGVHD Treated : Acute-graft-versus-host Disease : 2017-05-05 : Biological: Fecal microbiota fecal microbiota transplantation |
| Not yet recruiting |
: Clinical Trial With MSC for Graft Versus Host Disease Treatment : Acute Graft Versus Host Disease : 2016-01-19 : Drug: Adult Allogeneic Mesenchymal cells from adipose tissue. |
| Terminated |
: A Study of AbGn-168H in Patients With Steroid Refractory Acute Graft-vs-Host Disease After Donor Stem Cell Transplant : Acute Graft Versus Host Disease : 2015-05-01 : Biological: AbGn-168H Humanized monoclonal antibody |
| Terminated |
: Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation : Acute Graft-versus-host Disease : 2014-01-21 : Drug: salvage chemotherapy, total body irradiation there are no direct interventions to our patients. |
| Completed |
: Ectoin Dermatitis Cream 7% as First-line Therapy of Acute Skin Graft Versus Host Disease : Acute Graft Versus Host Disease in Skin : 2016-06-22 |
| Completed |
: Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation :
: 2007-11-21 :
|
| Completed |
: Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease : Graft Vs Host Disease : 2002-05-06 : Drug: ABX-CBL |
| Completed |
: Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD) :
: 2009-08-11 : Drug: Rifaximin Rifaximin for Bone marrow transplant patients |